(2S,4R)-1-((S)-3,3-dimethyl-2-propionamidobutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

ID: ALA4228328

PubChem CID: 122528991

Max Phase: Preclinical

Molecular Formula: C25H34N4O4S

Molecular Weight: 486.64

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C

Standard InChI:  InChI=1S/C25H34N4O4S/c1-6-20(31)28-22(25(3,4)5)24(33)29-13-18(30)11-19(29)23(32)26-12-16-7-9-17(10-8-16)21-15(2)27-14-34-21/h7-10,14,18-19,22,30H,6,11-13H2,1-5H3,(H,26,32)(H,28,31)/t18-,19+,22-/m1/s1

Standard InChI Key:  DAQZMDAVCMVVFQ-XQBPLPMBSA-N

Molfile:  

     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
    5.3209  -13.5126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0376  -13.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3255  -12.6878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0376  -14.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7521  -14.3376    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3230  -14.3376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0376  -15.5751    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.5055  -14.6680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0576  -14.0549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6450  -13.3405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8381  -13.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6793  -15.4746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0677  -16.0283    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4647  -15.7274    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6384  -16.5338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4238  -16.7866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5957  -17.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3801  -17.8442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9926  -17.2903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8154  -16.4801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0311  -16.2310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7784  -17.5419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0355  -18.3220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8605  -18.3186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1123  -17.5329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4427  -17.0508    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.5534  -18.9915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6085  -14.7501    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9805  -12.5867    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8941  -14.3376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8941  -13.5126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6085  -13.1001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1796  -14.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4651  -14.3376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  4  5  1  0
  4  6  1  0
  4  7  2  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  5  1  0
  8 12  1  1
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  1  0
 23 27  1  0
  6  1  1  1
  6 28  1  0
 10 29  1  6
 28 30  1  0
 30 31  2  0
  1 32  1  0
 30 33  1  0
 33 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4228328

    ---

Associated Targets(Human)

VHL Tchem Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 486.64Molecular Weight (Monoisotopic): 486.2301AlogP: 2.64#Rotatable Bonds: 7
Polar Surface Area: 111.63Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.60CX Basic pKa: 2.65CX LogP: 1.37CX LogD: 1.37
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.56Np Likeness Score: -0.63

References

1. Soares P, Gadd MS, Frost J, Galdeano C, Ellis L, Epemolu O, Rocha S, Read KD, Ciulli A..  (2018)  Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298).,  61  (2): [PMID:28853884] [10.1021/acs.jmedchem.7b00675]

Source